31 results were returned
International law firm Bird & Bird today boosts its Corporate practice with the appointment of life sciences expert Michiel Wurfbain as a partner in The Hague.
The Swedish listed company AddLife AB is a market leading player within Life Science offering quality products and advice to both the private and the public sectors, primarily in the Nordics and the rest of Europe.
Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.
Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...
International law firm Bird & Bird advises Indian vaccine manufacturer Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in German project management service provider Vakzine Projekt Management ...
International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy
European Medicines Agency (EMA) had communicated to third parties (with some omissions), information contained in toxicological test reports and clinical trial reports obtained in a MA application file on the grounds ...
Our international Life Sciences & Healthcare Group is extremely proud to have been recognised among individuals and companies behind the most innovative and challenging Life Sciences work of the past year, as well as ...
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")